Charlie Petty, Adjuvant Capital

Charlie Petty is a life sciences investor who co-founded Adjuvant Capital. See contact routes.

About Charlie Petty

Charlie Petty is a life sciences investor who co-founded Adjuvant Capital, a venture firm that invests $10–$25 million in early-stage companies developing vaccines, therapeutics, and diagnostics for high-burden and neglected diseases in low- and middle-income countries. His notable portfolio includes clinical-stage biotechs such as Excision Biotherapeutics, Codagenix, VitriVax, Minervax, and Alydia Health (acquired by Merck), and he serves on the boards of Codagenix and VitriVax. Petty’s distinctive thesis centers on a dual-mandate impact model that targets global public health challenges while balancing financial returns through sales in both wealthy and underserved markets.

Charlie Petty at a glance

Role
Managing Director
Organization
Adjuvant Capital
Location
New York, New York, United States
Investor type
Venture Capital

Frequently asked about Charlie Petty

What does Charlie Petty invest in?
We have not verified a stated sector or stage focus for Charlie Petty at Adjuvant Capital (New York, New York, United States). The profile lists the organization, location and investors we track alongside them.
How do I contact Charlie Petty?
Charlie Petty's published profile links (website, LinkedIn or X where available) are listed on the StartupFundraising.com investor profile.
Where is Charlie Petty based?
Charlie Petty is based in New York, New York, United States.

This profile is part of the StartupFundraising investor database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in New York.

Investors similar to Charlie Petty (24)

Browse related investor lists (2)

Compare Charlie Petty (8)

Investors like Charlie Petty · Full investor directory · Investor access · Company funding database